|
Symbol
|
RMAFFV | RMA9EV | ABKBTQ | PHKRCH | RMADDV | RMAH4V | RMBHZV | PMXRCH | RMA3WV | RMBSMV | PSNRCH | RMAVPV | ACJMTQ | MBUDJB | ACTKTQ | RMAXZV | Z0AYWZ | RMAEBV | RMALNV | RMBYGV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Auto-Callable Multi Defender VONTI |
|
Sous-jacent
|
Alcon / Galderma Group AG / Sandoz Group AG | Douglas Hldg. AG / Galderma Group AG / UNILEVER TMICC BASKET | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / Sanofi S.A. | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Galderma Group AG / Givaudan / Straumann Hldg. AG | DOCMORRIS AG / Galderma Group AG / Sandoz Group AG | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | Galderma Group AG / ON Holding AG. / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Novartis AG | Compagnie Financière Richemont SA / Galderma Group AG / L'Oréal S.A. / LVMH Moet Hennessy Louis Vuitton | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Galderma Group AG / Sandoz Group AG / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Galderma Group AG / Lonza Group N / Swatch Group I | Bayer AG / Galderma Group AG / Galenica AG / L'Oréal S.A. | Accelleron Industries AG / Galderma Group AG / Givaudan | Alcon / Galderma Group AG / Novartis AG / Roche PS / Sandoz Group AG | Galderma Group AG / Galenica AG / Ypsomed Hldg. AG | Galderma Group AG / Nestlé S.A. / Novartis AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
29.06.2026 | 28.09.2026 | 12.11.2026 | 02.09.2026 | 05.01.2027 | 10.07.2026 | 17.07.2026 | 24.07.2026 | 17.07.2026 | 07.08.2026 | 03.12.2026 | 22.03.2027 | 17.09.2026 | 28.09.2026 | 01.10.2026 | 28.09.2026 | 08.07.2027 | 25.05.2027 | 07.12.2026 | 10.12.2026 |
| Demande | 67,40 | 47,400 | 96,53 | 84,69 | 99,40 | - | 76,70 | 53,86 | - | 62,90 | 95,94 | - | 58,18 | - | 101,79 | - | - | 90,30 | 96,70 | 101,00 |
| Offre | - | - | 97,33 | - | 100,40 | - | - | - | - | - | 96,74 | - | - | - | 102,61 | - | - | 91,30 | 98,10 | 102,00 |